Medicine
fromenglish.elpais.com
1 week agoA newly-discovered molecular process explains how our bodies perceive the cold
Research on the TRPM8 protein reveals its role in cold sensation, potentially leading to new treatments for cold-induced pain.
Enzymatic inhibitors are indispensable tools for dissecting biological pathways and developing therapeutic interventions1. They are broadly categorized by their binding sites and mechanisms of action. Among these, orthosteric inhibitors, which bind to the catalytic site and directly compete with substrates, have been extensively explored due to their predictable structure-activity relationships. However, such inhibitors are typically substrate-agnostic, as their mechanism relies solely on blocking the active site.